Merck held an investors’ day. Summarising findings and discussions, Merck confirmed our positive view. Management delivered what it had announced some years ago. 2020 growth as well as margin drivers (e.g. higher drug sales of recently-approved drugs, continued demand for single-use (biologicals) production). Nevertheless, there were also some clouds (e.g. timing of semiconductor’s recovery) and some effects partly weighing on margins. All in all, the three divisions will show a v
12 Sep 2019
A healthy mix of (growth) drivers
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
A healthy mix of (growth) drivers
Merck KGaA (MRCK:WBO) | 0 0 1.2% | Mkt Cap: 10,792m
- Published:
12 Sep 2019 -
Author:
Martin Schnee -
Pages:
4
Merck held an investors’ day. Summarising findings and discussions, Merck confirmed our positive view. Management delivered what it had announced some years ago. 2020 growth as well as margin drivers (e.g. higher drug sales of recently-approved drugs, continued demand for single-use (biologicals) production). Nevertheless, there were also some clouds (e.g. timing of semiconductor’s recovery) and some effects partly weighing on margins. All in all, the three divisions will show a v